Article
Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity.
Cancer chemotherapy and pharmacology - 1 Jan 1997
An W G, Schnur R C, Neckers L, Blagosklonny M V
Abstract excerpt
PURPOSE: Recently, it has been shown that geldanamycin (GA), a benzoquinone ansamycin, is able to deplete mutant p53, p185erbB2 and Raf-1 proteins in cancer cells. However, the relationship between these activities of GA and its antiproliferative activity is not clear. Here we investigated the effects of 28 GA derivatives in SKBr3, a human breast cancer cell line. METHODS: We performed Western blot analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
